952511-32-9 Usage
Chemical Structure
1H-Benzimidazole-7-carboximidamide, N-hydroxy-
Explanation
1H-Benzimidazole-7-carboximidamide, N-hydroxy- is a derivative of benzimidazole, which is a fused-ring system consisting of a benzene ring and an imidazole ring. The N-hydroxy group is attached to the nitrogen atom at the 7th position of the benzimidazole ring.
Explanation
1H-Benzimidazole-7-carboximidamide, N-hydroxyis used as a building block in organic synthesis due to its versatile chemical structure, which allows for the creation of various nitrogen-containing compounds.
Explanation
1H-Benzimidazole-7-carboximidamide, N-hydroxy- is used in medicinal chemistry to develop new drug candidates and pharmaceutical intermediates, as its structure can be modified to target specific biological receptors or enzymes.
Explanation
1H-Benzimidazole-7-carboximidamide, N-hydroxyhas been investigated for its potential biological activities, which include anti-tumor (cancer-fighting) and anti-inflammatory effects.
Explanation
Due to its unique chemical structure and potential biological activities, 1H-Benzimidazole-7-carboximidamide, N-hydroxy- is considered for use as a pharmaceutical intermediate, which can be further modified to create new drug candidates for various therapeutic applications.
Building Block in Organic Synthesis
Yes
Medicinal Chemistry Applications
Yes
Biological Activities
Anti-tumor and anti-inflammatory properties
Potential Use
Pharmaceutical intermediate and new drug development
Check Digit Verification of cas no
The CAS Registry Mumber 952511-32-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,2,5,1 and 1 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 952511-32:
(8*9)+(7*5)+(6*2)+(5*5)+(4*1)+(3*1)+(2*3)+(1*2)=159
159 % 10 = 9
So 952511-32-9 is a valid CAS Registry Number.
952511-32-9Relevant academic research and scientific papers
HETERO COMPOUND
-
Page/Page column 18-19, (2009/01/24)
[Problems] To provide a useful compound as an active ingredient for a preventing and/or treating agent for rejection in the transplantation of an organ, bone marrow, or a tissue, an autoimmune disease, or the like, which has an excellent S1P1 a
